MENU
CATX
Stock ticker: ASE
PRICE
CHANGE
CAPITALIZATION
Perspective Therapeutics (CATX) Earnings Date & Reports
Perspective Therapeutics Inc is a radiopharmaceutical development company that is pioneering advanced treatment applications for cancers throughout the body... Show more
Industry: #Biotechnology
A.I. Advisor
published Earnings
CATX is expected to report earnings to rise 9.09% to -23 cents per share on November 09
Q3'26
Est.
$-0.24
Q2'26
Beat
by $0.04
Q1'26
Beat
by $0.05
Q4'25
Missed
by $0.16
Q3'25
Missed
by $0.03
The last earnings report on August 10 showed earnings per share of -21 cents, beating the estimate of -25 cents. With 430.61K shares outstanding, the current market capitalization sits at 262.55M.
View a ticker or compare two or three
VS
VS
Interact to see
Advertisement
Advertisement
A.I.Advisor
published price charts
Interesting Articles
A.I. Advisor
published General Information
General Information
a producer of therapeutic radioactive isotopes
Industry MedicalNursingServices
Industry
Biotechnology
Address
2401 Elliott Avenue
Phone
+1 206 676-0900
Employees
140
Web
https://www.perspectivetherapeutics.com